Bridge to Life™ Unveils Groundbreaking 12-Month Clinical Trial Data on HOPE at World Transplant Congress 2025

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Bridge-to-Life,Ltd-UK

More Like This

PR Newswire associated0

Bridge to Life Announces Abstract Presentations at The 2025 International Congress of the International Liver Transplantation Society (ILTS) in Singapore, May 28-31, 2025

PR Newswire associated0

Bridge to Life Ltd. Achieves Global Milestone Using Hypothermic Oxygenated Perfusion (HOPE) and VitaSmart™ System

PR Newswire associated0

Italian Studies Confirm Safety of HOPE (Hypothermic Oxygenated PErfusion) for Liver Transplantation and Value of HOPE in Identifying Biomarkers for Assessing Liver Viability

PR Newswire associated0

Portuguese Transplant Center Analysis of First 100 Cases of Hypothermic Oxygenated PErfusion (HOPE) in Liver Transplantation Demonstrates Increased Use of Marginal Grafts, Making More Livers Available for Transplantation

PR Newswire associated0

Bridge to Life Acquires VitaSmart™ Hypothermic Oxygenated Machine Perfusion System from Medica S.p.A.

PR Newswire associated0

Bridge to Life Achieves ISO 13485:2016 Certification, Reinforcing Commitment to Quality and Safety in Hypothermic Oxygenated Perfusion and Cold Flush Organ Preservation Solutions

PR Newswire associated0

Bridge to Life and ULS Coimbra Announce Collaboration to Enhance Preservation of Livers Awaiting Transplantation

OrganOx Opens State-of-the-Art Research, Development, and Production Headquarters in Oxford, UK